FDA Adverse Event Other Summary report: N

RADIESSE DERMAL FILLER

MDR report key: 2424873 · Received January 13, 2012

Report

Report Number
2135225-2012-00003
Event Type
Other
Date Received
January 13, 2012
Date of Event
December 8, 2011
Report Date
December 22, 2011
Manufacturer
MERZ AESTHETICS, INC.
Product Code
LMH
PMA / PMN Number
P050052
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE HISTORY RECORDS WERE NOT REVIEWED. A LOT NUMBER WAS NOT PROVIDED.

Description of Event or Problem · 1

THIS REPORT WAS FORWARDED TO MERZ AESTHETICS BY (B)(4) AT MERZ PHARMA (B)(4). A FEMALE, PT, WAS INJECTED WITH TWO 0.8 CC RADIESSE SYRINGES INTO CHEEKBONES ON (B)(6) 2011, AND ON (B)(6) 2011, DEVELOPED BILATERAL INFLAMMATORY EDEMA (CHEEKBONES) WITHOUT PAIN, TREATED WITH ANTIBIOTICS PER "OS" PLUS CORTICOSTEROIDS (SOLUPRED). ON (B)(6) 2012, DR. (B)(6) MERZ (B)(6)FORWARDED AN UPDATE TO MERZ AESTHETICS. DR. (B)(6) REPORTED THE EVENT AS "2 INFLAMMATORY CHEEKBONES" FOLLOWING THE RADIESSE INJECTION MANIFESTED AS EDEMA AND REDNESS; MODERATE INTENSITY AND ONGOING. SINCE (B)(6) 2012, THE PT WAS TREATED WITH DIPROSONE CREAM, 2 TIMES DAILY FOR 6 DAYS LEADING TO TRANSIENT IMPROVEMENT; SOLUPRED (PREDNISOLONE) AND ORBENINE (CLOXACILLIN) FOR 6 DAYS. NO LIDOCAINE WAS ADDED TO THE RADIESSE SYRINGES. INDICATION FOR RADIESSE INJECTIONS WAS LISTED AS "INCREASING VOLUME OF CHEEKBONES." CAUSALITY RELATIONSHIP LISTED AS "PROBABLY." THE PT HAD PREVIOUS RADIESSE INJECTION "SINCE (B)(6) 2010, 8 VIALS." DR. (B)(6) STATED THE EVENT IS NOT SERIOUS, HOWEVER, HE ADDED THAT THE CONDITION REQUIRED MEDICAL/SURGICAL INTERVENTION AND THE INCIDENT IS CONSIDERED MEDICALLY IMPORTANT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 RADIESSE DERMAL FILLER RADIESSE INJECTABLE IMPLANT LMH MERZ AESTHETICS, INC. UNK X 2

Patients

Seq Age Sex Outcome Treatment
1 76 YR Other